Every number on this page is drawn from documented, real-world engagements at Fortune 100 companies. Not projections. Not estimates. Actual outcomes.
Five internal and two external global strategy teams operating in silos, with fragmented data health, manual reporting, and no unified analytics COE across $7B global spend.
Built strategic global COE combining all teams. Deployed automated data architecture with neural network of data connections. Created US and EU Warsaw centers. Implemented GPT AI for specialized expertise enhancement.
$225M cost reduction over 3 years · 40% data health improvement · 50% data velocity increase · 250+ hours manual work eliminated · 100% compliance rating
Analytics insights underutilized across multinational R&D Quality organization. Low adoption, disconnected stakeholders, insufficient leading indicator monitoring.
Led multinational matrixed COE. Implemented stakeholder mapping, road shows, and survey deployment. Built scalable data ecosystems with forward-looking signal detection and leading indicator focus.
75% viewership usage increase · Improved risk mitigation for inspections · Stronger QMS alignment across Business Process Network
Inefficient lead targeting and manual ETL processes limiting Medicare/Medicaid growth across pharmacy and healthcare channels.
Created marketing attractiveness score enabling macro and micro-targeting. Reduced ETL time 25% by automating shortest-path. Utilized IQVIA & Komodo pharma data for pharmacy risk modeling.
25% YOY lead conversion improvement · Five Stars five consecutive years · 100% HIPAA compliance · 25% ETL time reduction
Ron's recommendations are public on LinkedIn — read what executives and peers say about the work.